Drug Delivery Market Analysis 2025

Table of Contents

Chronic diseases tend to worsen over time, creating a significant burden on patients, their families, and society.

Download PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00029924?utm_source=Open_PR&utm_medium=10392

According to the International Diabetes Federation (IDF), about 425 million people were living with diabetes in 2017, and this number is expected to reach 629 million by 2045. Diabetes is a life-threatening chronic disease for which there is no specialized cure. Diabetes can lead to number of complications in different parts of the body, increasing the risk of premature death. Major complications associated with diabetes include kidney failure, heart attack, stroke, leg amputation, vision loss, and nerve damage. The number of diabetes cases has been increasing significantly worldwide.

Market leaders and key company profiles

Pfizer Inc,

Johnson & Johnson,

Becton Dickinson and Co,

Novo Nordisk AS,

Boston Scientific Corp,

Baxter International Inc,

Gerresheimer AG,

Kindeva drug delivery LP,

GlaxoSmithKline Plc,

Bausch Health Companies,

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

This release was published on openPR.